Cervical Ripening at Home or In-Hospital – prospective cohort study and process evaluation
Our aim is to compare home versus in-hospital cervical ripening to determine whether home cervical ripening is within an acceptable margin of in-hospital cervical ripening for the safety outcome of neonatal unit (NNU) admission, whether it is more acceptable to women and whether it is cost-effective from both NHS and patient perspectives.
Chief Investigator: Dr Sarah Stock
Number and location of participating sites / geographical scope (by region/ country): Expected 30 sites (18 sites open, 5 in set up)
EudraCT number: N/A
ISRCTN number: 32652461
Funder: NIHR HTA
Start and End date
Of grant award: 01/12/2019 - 30/11/2022
Of recruitment: Ongoing
Current status: In recruitment
UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.
Dr Sarah Stock, Usher Institute of Population Health Sciences and Informatics, NINE Edinburgh BioQuarter, 9 Little France Road, Edinburgh, EH16 4UX
Trial Manager: CHOICE.Study@ed.ac.uk
ECTU Involvement: Trial Management, Statistics, Data Management